Top Page
Fiji Kava Limited
(Sydney:CCO)
Fiji Kava Limited (CCO) vs. iShares MSCI Australia ETF (EWA)
Fiji Kava Limited Business Overview & Revenue Model
Fiji Kava Limited Financial Statement Overview
| Breakdown | ||||
| Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 4.26M | 1.78M | 2.08M | 1.16M | 758.87K | Gross Profit |
| 2.05M | -1.40M | 665.97K | 404.43K | 184.33K | EBIT |
| -1.88M | -4.30M | -5.42M | -3.28M | -3.69M | EBITDA |
| -3.35M | -4.86M | -5.72M | -3.19M | -3.56M | Net Income Common Stockholders |
| -3.73M | -5.24M | -5.46M | -3.39M | -3.81M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 1.10M | 462.15K | 799.22K | 1.18M | 1.43M | Total Assets |
| 4.33M | 3.24M | 4.79M | 3.60M | 2.95M | Total Debt |
| 2.21M | 2.35M | 1.08M | 125.00K | 750.38K | Net Debt |
| 1.11M | 1.92M | 278.21K | -1.06M | -679.85K | Total Liabilities |
| 4.80M | 3.32M | 2.51M | 694.78K | 1.56M | Stockholders Equity |
| -466.84K | -87.53K | 2.28M | 2.91M | 1.38M |
| Cash Flow | Free Cash Flow | |||
| -2.19M | -3.82M | -7.10M | -4.40M | -3.67M | Operating Cash Flow |
| -2.08M | -3.80M | -6.14M | -4.14M | -3.54M | Investing Cash Flow |
| -116.97K | -21.08K | -964.94K | -259.37K | -135.57K | Financing Cash Flow |
| 2.83M | 3.47M | 6.03M | 4.16M | 2.79M |
Fiji Kava Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
65 Neutral | $8.88B | 15.03 | 4.75% | 203.74% | 3.58% | -2.49% | |
36 Underperform | AU$9.03M | ― | -548.03% | ― | 192.34% | 68.06% | |
| $25.71M | ― | -75.39% | ― | ― | ― | ||
| $7.80M | ― | -177.18% | ― | ― | ― | ||
73 Outperform | AU$110.36M | 12.67 | 18.35% | 5.00% | 7.21% | -4.07% | |
53 Neutral | AU$647.09M | ― | -56.99% | ― | 10.76% | -195.89% | |
34 Underperform | AU$4.75M | ― | -105.17% | ― | -3.82% | 51.47% |
Fiji Kava Limited Corporate Events
The Calmer Co International Limited has issued 37,500 fully paid ordinary shares following the exercise of options, as per the Corporations Act 2001. This move, authorized by the company’s Board of Directors, reflects compliance with relevant legal provisions and indicates no excluded information is required to be disclosed. This issuance could impact the company’s financial structure and stakeholder interests.
The Calmer Co. International Limited has announced a significant expansion in the distribution of its flagship kava products, Taki Mai Kava-shot and FijiKava Instant Kava, in Coles Supermarkets across Australia. The Taki Mai Kava-shot is now available in 797 stores, and the FijiKava Instant Kava is in 801 stores, reflecting a 59% and 170% increase in store coverage, respectively. This expansion is driven by the growing consumer demand for natural wellness products that offer functional alternatives to alcohol. The company views this growth as a validation of its strategy and leadership in the kava market, further strengthening its brand presence in the Australian retail channel.
The Calmer Co International Limited has announced a change in the director’s interest notice, specifically regarding John Homewood. Homewood Venture Capital Pty Ltd and Ace Property Holdings Pty Ltd, both associated with Mr. Homewood, have increased their holdings in the company through the acquisition of additional fully paid ordinary shares and options. This change reflects an allocation of shares and options pursuant to a rights offer, potentially impacting the company’s market positioning by increasing insider holdings.
The Calmer Co International Limited has announced the quotation of new securities on the Australian Securities Exchange (ASX). The company will be quoting 75,666,667 ordinary fully paid shares and 37,833,335 options expiring on June 30, 2026. This move is part of previously announced transactions and may impact the company’s market presence by potentially increasing liquidity and investor interest.
The Calmer Co. International Limited has successfully completed its renounceable rights issue, raising $1,000,713 before costs. This capital will be allocated towards capital expenditure, inventory expansion, marketing, brand promotion, and general working capital. The company’s directors and management have shown strong commitment by participating in the rights issue, reflecting confidence in the company’s future. The issuance of new shares and options is scheduled for May 16, 2025, with Mahe Capital Pty Ltd acting as the lead manager and underwriter.
The Calmer Co. International Limited reported a significant 104% year-on-year increase in its USA Amazon sales for April 2025, reaching AUD$203,000. This growth is attributed to the strong performance of its Taki Mai traditional kava brand, which accounted for 24% of the sales, and a notable rise in subscription sales, making up 28% of the total sales volume. The company is strategically expanding its presence in the U.S. market by focusing on both its instant kava brand, Fiji Kava, and its heritage brand, Taki Mai, to capture different market segments. This expansion is part of a broader strategy to launch new products and invest in R&D for long-term success.
The Calmer Co. International Limited has signed a non-binding Memorandum of Understanding with Leilo, a leading US functional beverage company, to supply high-grade noble kava powders from the South Pacific to US kava bars. This partnership aims to expand The Calmer Co.’s presence in the North American market, leveraging its expertise in kava supply and supporting the growing demand for non-alcoholic beverages. The collaboration is expected to enhance the company’s market positioning and provide a stable supply chain for Leilo’s kava bar partners, potentially leading to a formal long-term supply agreement.
The global kava root extract market is projected to grow significantly, reaching USD 5.6 billion by 2033, driven by the food and beverage industry’s growth, increased use in cosmetics and personal care, and extensive R&D activities. This growth presents opportunities for Fiji Kava Limited to enhance its market positioning and expand its operations, benefiting stakeholders by tapping into the rising demand for natural relaxation products.
The Calmer Co. International Limited has announced a pro rata renounceable entitlement offer to raise approximately $2.2 million. Eligible shareholders can subscribe for two new shares for every seven existing shares held, with the offer including a free attaching option. This capital raising initiative is aimed at strengthening the company’s financial position and potentially expanding its market presence.
The Calmer Co. International Limited has issued 123,873,702 fully paid ordinary shares along with the same number of attaching CCOOA options. This issuance was done without disclosure to investors under Part 6D.2 of the Corporations Act 2001, and the company confirms compliance with relevant provisions of the Act. This strategic move is expected to enhance the company’s financial standing and operational capabilities, potentially impacting its market position and stakeholder interests positively.
The Calmer Co International Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The company is set to quote 1,666,666 options with an expiration date of June 30, 2026, as part of previously announced transactions. This move is part of the company’s strategic efforts to enhance its market presence and provide more investment opportunities for stakeholders.
The Calmer Co International Limited has announced the application for quotation of 1,666,666 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code CCO. This move signifies a strategic step in enhancing the company’s market presence and potentially increasing its shareholder base, reflecting a positive outlook for future growth and stakeholder engagement.
The Calmer Co International Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). This involves the listing of 122,207,036 options expiring on June 30, 2026, which were part of a previously announced transaction. This move is likely to impact the company’s market presence by increasing the liquidity of its securities and potentially attracting more investors.
The Calmer Co International Limited has announced a new issuance of 122,207,036 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code CCO. This move is part of the company’s strategic efforts to enhance its market presence and provide liquidity to its shareholders, potentially impacting its operational dynamics and positioning within the industry.
The Calmer Co. International Limited has expanded its partnership with the Fiji Rugby Union by launching a new range of co-branded kava products, including instant kava powder and cold-pressed kava shots infused with dehydrated coconut water powder. This launch is significant for The Calmer Co. as it strengthens its position as the exclusive kava supplier to Fiji Rugby, highlighting the cultural and nutritional importance of coconuts to the Fijian people and rugby community. The products will be available in tourist retail outlets across Fiji and on Amazon USA, with a 10% royalty on sales paid to channel partners.
The Calmer Co. International Limited announced the commencement of trading for the rights to its Renounceable Rights Issue under the ASX code CCOR. This development marks a significant step in the company’s financial strategy, potentially enhancing its market presence and providing stakeholders with new investment opportunities.
The Calmer Co International Limited has announced a renounceable pro-rata entitlement offer to raise approximately $2.2 million by issuing up to 729,677,511 new shares. The offer is underwritten to $500,000 by Mahe Capital Pty Ltd and includes a Top Up Offer for eligible shareholders to subscribe for additional shares. This initiative aims to enhance the company’s capital structure and provide financial flexibility, potentially impacting its market positioning and shareholder value.
The Calmer Co International Limited has announced a proposed issue of securities, including a standard pro rata issue of 729,677,511 ordinary fully paid shares and 364,838,756 options expiring on 30 June 2026. Additionally, a placement or other type of issue will see the issuance of 44,000,000 options. The announcement outlines key dates, including the ex-date on 17 April 2025, the record date on 22 April 2025, the offer closing date on 9 May 2025, and the issue date on 16 May 2025. This move is part of the company’s strategy to raise capital and potentially enhance its market position.
The Calmer Co International Ltd, a company listed on the ASX, has announced a renounceable entitlement offer to raise up to $2.2 million. This offer allows eligible shareholders to subscribe for two new shares for every seven existing shares at a price of $0.003 per share, which is a 50% discount to the last traded price. Additionally, shareholders will receive one free option for every two new shares, with an exercise price of $0.006 and an expiration date of June 30, 2026. The funds raised will be used to expand inventory, upgrade manufacturing equipment, and support marketing activities in Australia and the USA, as well as for new product launches and general working capital.
The Calmer Co International Limited, listed on the Australian Securities Exchange under the code CCO, has requested a trading halt for its securities. This halt is pending an announcement related to a proposed capital raising, which is expected to be disclosed before the opening of trading on April 16, 2025. The company believes this halt is necessary to prevent uninformed trading and has been approved by the Board of Directors.
The Calmer Co. International Limited has issued a total of 3,801,004 fully paid ordinary shares and 3,324,163 CCOOA options as part of its recent financial activities, targeting professional investors. This strategic move is expected to enhance the company’s market presence and operational capabilities, potentially impacting its industry positioning favorably.
The Calmer Co International Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The company is issuing 955,683 ordinary fully paid shares and 477,842 options expiring on June 30, 2026, to existing professional investors. This move is expected to enhance the company’s financial position and potentially strengthen its market presence.
The Calmer Co. International Limited has appointed Matthew Kowal as its new Chief Commercial Officer. Kowal, who brings over 20 years of experience in the beverage industry, will be responsible for overseeing sales, marketing, and strategic partnerships to drive growth initiatives both locally and internationally. His appointment comes at a time when the global kava market is experiencing significant growth, with sales expected to rise by over 14% annually. Kowal’s expertise in scaling beverage brands and executing market entry strategies is expected to play a crucial role in The Calmer Co.’s expansion efforts and its aim to make premium quality kava accessible worldwide.
The Calmer Co International Limited has announced a new application for the quotation of securities on the Australian Securities Exchange (ASX). The announcement details the issuance of 2,846,321 options expiring on June 30, 2026, which are part of previously announced transactions. This move is likely to have implications for the company’s market operations and could influence its positioning within the industry.
The Calmer Co International Limited, listed under the ASX code CCO, has announced a new issuance of 2,846,321 ordinary fully paid securities, which were quoted on March 21, 2025. This move indicates the company’s strategic efforts to potentially enhance its market position and provide additional value to its stakeholders.
The Calmer Co. International Limited has appointed Andy Burger, a former senior buyer at Amazon, as the Head of E-Commerce to spearhead its direct-to-consumer expansion and transition to the Acuity e-commerce platform. This strategic move aims to optimize product visibility, improve customer engagement, and accelerate revenue growth across major online marketplaces. The transition to Acuity aligns with the company’s digital-first strategy, leveraging advanced AI-driven analytics and automation to enhance operational efficiency and support global expansion. The company is also on track to expand its product line with new kava-based offerings, capitalizing on the growing popularity of kava in the global market.